1154338

InfuScience, Inc. dba Bioscrip Infusion Services — FEI 3013352224

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
October 8, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chantilly, VA (United States)

Citations

IDCFRDescription
18949FDCA 501(a)(2)(A)First pass air blockage, open unit with sterile product
18956FDCA 501(a)(2)(A)Cleanliness, ISO-classified areas